BioSpace News Archive

Elicio Therapeutics, a next generation immuno-oncology company, announced today that it has closed its $33 million Series B financing. Proceeds from the financing will be used to advance Elicio’s pipeline of novel lymph node targeted immuno-therapies, including ELI-002, an Amphiphile mKRAS vaccine (AMP KRAS). ELI-002 targets all seven KRAS mutations that drive 99% of all mKRAS-driven cancers, estimated to be 25% of all human solid tumors.

Data shows that 45 percent of Medicare beneficiaries are “not sure” if their plan offers digital access to a patient portal, 18 percent said they have “no access”

LetsGetChecked recognized for achievements in home health testing

Geneoscopy, Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, today announced a successful and oversubscribed $6.9 million Series A financing

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced two poster presentations at the 24th Annual International Congress of the World Muscle Society (WMS).

New anti-CGRP treatment for the prevention of migraine in adults with at least 4 migraine days per month

Audacious Inquiry (Ai) and the Texas Health Services Authority (THSA) to deploy Emergency Department Encounter Notifications (EDEN), powered by Ai’s care coordination platform, Encounter Notification Service® (ENS®), to improve care outcomes across the entire State of Texas

Turner Imaging Systems, a developer of advanced X-ray imaging systems, announced the company has received FDA 510 clearance for its Smart-C Mini-C Arm Portable Fluoroscopy and X-Ray Imaging Device.

Health Canada is advising Canadians that the following products were seized because they may pose serious health risks.

Certain fungi move from the gut to the pancreas, expand their population more than a thousand-fold, and encourage pancreatic cancer growth, a new study finds.